| Dr Robert Jay Sinsheimer, MD | |
|
445 E Granville Rd, Worthington, OH 43085-3192 | |
| (614) 293-2850 | |
| (614) 293-2849 |
| Full Name | Dr Robert Jay Sinsheimer |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 445 E Granville Rd, Worthington, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497735344 | NPI | - | NPPES |
| 41598 | Other | AZ | ARIZONA MEDICAL BOARD |
| 35-03-9537 | Other | OH | LICENSE NUMBER OHIO |
| 0122138 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35-03-9537 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Jay Sinsheimer, MD 445 E Granville Rd, Worthington, OH 43085-3192 Ph: (614) 293-2850 | Dr Robert Jay Sinsheimer, MD 445 E Granville Rd, Worthington, OH 43085-3192 Ph: (614) 293-2850 |
News Archive
British researchers have discovered a new way of detecting which breast cancer patients are going to respond best to chemotherapy that includes anthracycline antibiotics. The study has found that an abnormality on chromosome 17, called CEP17, is not only associated with a worse outcome for patients, but also that its presence is a highly significant indicator that the tumour will respond to anthracyclines. The research will be presented at the European Breast Cancer Conference (EBCC7) Thursday 25th March.
Research over decades has implicated aberrant autophagy and lysosomal function as reliable markers and therapeutic targets for neurodegenerative diseases.
The drug aflibercept (trade name: Eylea) has been approved in Germany since November 2012 for the treatment of wet age-related macular degeneration (AMD). In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the current standard therapy.
Medical College of Wisconsin researchers in Milwaukee have reported that children of Alzheimer's patients who are carriers of a genetic risk factor for Alzheimer's disease have neurological changes that are detectable long before clinical symptoms may appear.
› Verified 6 days ago
Dr. Jeffrey L Hunter, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 445 E Granville Rd, Worthington, OH 43085 Phone: 614-293-2850 | |
Veronique Bartman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 W Wilson Bridge Rd, Worthington, OH 43085 Phone: 614-293-2850 Fax: 614-293-2849 | |
Scott Michael Reineck, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 874 Proprietors Rd, Worthington, OH 43085 Phone: 614-885-9405 Fax: 614-885-9481 | |
Eugenia L Kim, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 874 Proprietors Rd, Worthington, OH 43085 Phone: 614-885-9405 Fax: 614-885-9481 | |
Dr. Harkiran Singh, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 W Wilson Bridge Rd, Worthington, OH 43085 Phone: 614-293-2850 Fax: 614-293-2849 | |
Elizabeth S Unk, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 874 Proprietors Rd, Worthington, OH 43085 Phone: 614-885-9405 Fax: 614-885-9481 | |
John M Jonesco, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 445 E Dublin Granville Rd, Worthington, OH 43085 Phone: 614-293-2850 Fax: 614-293-2849 |